PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc Bio-e Deep Dive Webinar Transcript

Jun 05, 2020 / 02:00PM GMT
Release Date Price: €41.4 (-4.61%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the PTC Bio-e Deep Dive. (Operator Instructions)

I would now like to introduce your host for today's conference call, Mr. Alex Kane. You may begin, sir.

Alex Kane;Stuart W. Peltz
PTC Therapeutics, Inc. - IR Officer;PTC Therapeutics, Inc. - Co-Founder, CEO

Thank you, and good morning, everybody. Hello, and thank you for joining us today for our first Deep Dive webinar on the Bio-e platform. With me on today's call is our Chief Executive Officer, Stuart Peltz; and our Chief Development Officer, Matt Klein.

We are excited to be hosting today's deep dive, as well as the upcoming series of deep dive webinars on our platforms and programs throughout the summer and the fall. In today's webinar, we will provide a detailed overview of the Bio-e platform, review prior clinical results for the lead Bio-e compound and outline expectations for the 3 upcoming Bio-e clinical trials.

With that, let me pass the call over to our CEO, Stuart Peltz. Stu?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot